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Abstract
Rheumatoid arthritis (RA) and rat models of RA exhibit symmetrical mirror-image spread. Many studies have sought to understand
the underlying mechanisms and have reported contralateral effects that are manifested in many different forms. It is now well
accepted that neurogenic mechanisms contribute to the symmetrical spread of inﬂammation. However, very few investigators have
directly assessed changes in contralateral nerve function and there is a paucity of data. In the present study our aim was to
investigate whether there are changes, in particular in the nervous system but also in the vascular system contralateral to an inﬂamed
rat knee joint, that might precede overt inﬂammation and symmetrical spread. Three to ﬁve days following Complete Freund’s
Adjuvant (CFA) injection we found spontaneous antidromic (away from the CNS) activity in the homologous sensory nerve
contralateral to the inﬂamed joint. Antidromic activity of this nature is known to result in the peripheral release of pro-inﬂammatory and
vasoactive neuropeptides. Importantly, this activity was modulated by systemic analgesic treatment. Furthermore, levels of Evans
blue dye extravasation were signiﬁcantly increased in the joint contralateral to inﬂammation, indicating altered vascular function.
These data suggest that contralateral increases in sensory neural activity and vascular function may account for the symmetrical
spread of RA, and that early analgesic treatment may prevent or delay the spread of this debilitating disease.
Introduction
Symmetry of inﬂammation is a fundamental characteristic of
rheumatoid arthritis (RA; Arnett et al., 1988) and leads to widespread
severe joint malformation and immobility (Clarke et al., 1994;
Zangger et al., 2005). Despite a large literature on the aetiology and
pathogenesis of RA, there is little understanding of the cause(s) of the
symmetry of this disease.
Whilst the immune response is of obvious importance in RA
progression, it is difﬁcult to understand how this alone can underlie the
symmetrical pattern of joint involvement. Levine and colleagues
proposed that this symmetry might be underpinned by joint innerva-
tion, and proposed a neurogenic contribution to both existing
inﬂammation and the symmetrical pattern of RA (Levine et al.,
1985a,b; Levine & Basbaum, 1990). A considerable body of evidence
now supports the ‘neurogenic’ hypothesis (Donaldson et al., 1995;
Rees et al., 1996; Decaris et al., 1999). Epidemiological studies
demonstrate that affected joints tend to show a mirror-image pattern
(Egger et al., 1995; Zangger et al., 2005). Patients who develop RA
after nerve injury show sparing of denervated joints (Thompson &
Bywaters, 1962; Glick, 1967; Glynn & Clayton, 1976; Veale et al.,
1993), and RA can resolve in affected joints that subsequently lose
their sensory innervation (Lapadula et al., 1997).
Animal models of RA support the neurogenic hypothesis. The well-
established Complete Freund’s Adjuvant (CFA) model in rats shows
symmetry of joint involvement after 2–4 weeks, depending on the site
and concentration of CFA injection (Donaldson et al., 1993; Decaris
et al., 1999). CFA-induced inﬂammation remains unilateral following
lesioning of the contralateral homologous nerve with the neurotoxin
capsaicin (Donaldson et al., 1995), implicating vanilloid receptor
subtype 1 (TRPV1; also known as VR-1)-expressing neurons in the
spreadofinﬂammation.Further,mechanicallyevokedantidromic(away
from the CNS) neuronal activity has been recorded in the contralateral
articular nerve (Rees et al., 1996). The vasoactive neuropeptides
substance P (SP) and calcitonin gene-related peptide (CGRP) are
released from primary afferent terminals following activation (White &
Helme, 1985); they increase both vascular permeability and vasodila-
tation(Brainetal.,1985;Ferrell&Russell,1986;Holzer,1998)andare
chemotaxic for lymphocytes, thereby initiating inﬂammation (Helme
et al., 1987; Mantyh, 1991; Holzer, 1998). Synovial SP and CGRP
contentincreasesrapidlyandbilaterallyfollowingtheinductionofCFA
arthritis (Bileviciute et al., 1993) and probably contributes to contra-
lateral joint involvement (Lam et al., 2004).
Although it is now widely accepted that the nervous system plays
an important role in the contralateral spread of inﬂammation, much of
this understanding is based on nerve lesion studies. Very few studies
have directly studied the function of contralateral nerves in models of
RA. Our aim was to test the hypothesis that contralateral nerve
function is altered following the development of arthritis. Further, our
study aimed to determine whether and how this altered function might
be modulated, and whether there are covert changes indicative of
inﬂammation in the contralateral joint.
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Animals
All procedures on animals were performed in accordance with United
Kingdom legislation [Animal (Scientiﬁc Procedures) Act, 1986], were
licensed by the UK Home Ofﬁce and follow the guidelines of the
International Association for the Study of Pain (Zimmermann, 1983).
Male Wistar rats (250–300 g) were obtained from B and K (Bristol,
UK), housed four per cage and maintained on ad libitum food and
water with a 12 h light–dark cycle.
Drugs
Sodium pentobarbital was obtained in its sodium salt form from Sigma
(Dorset, UK) and was made up in-house to allow i.p. and i.v. injection
for anaesthetic induction and maintenance, respectively. Capsaicin
was obtained from Tocris (Bristol, UK) and was made up in a 10%
ethanol, 10% Tween 80 and 80% saline vehicle. Dipyrone (metamizol)
was obtained from Sigma (Dorset, UK) and was dissolved in saline.
Lignocaine, 2%, was obtained from Deproco Ltd (Kent, UK).
Induction of CFA-induced inﬂammation
A brief anaesthesia was induced with halothane (3% in O2); once
areﬂexia was achieved 250 lg⁄100 lLC F A( Mycobacterium
tuberculosis in mineral oil vehicle) was injected through the patellar
tendon into the right knee joint to induce arthritis (Rees et al., 1994).
Rats were returned to the home cage and allowed to recover, and were
monitored daily for gait disturbances. Ipsilateral and contralateral knee
joint diameter measurements were taken from arthritic rats using
callipers on the day of electrophysiological experiments.
Surgical procedures
Three to ﬁve days following intra-articular injection of CFA, anaes-
thesia was induced with sodium pentobarbital (60 mg⁄kg, i.p.) and
the external jugular vein and trachea were cannulated for mainte-
nance of anaesthesia (10 mg⁄kg⁄ h, i.v.) and clearing of the airway,
respectively. Core body temperature was maintained (36.5–37.5  C)
by the use of a rectal temperature probe connected to a heating lamp
via a feedback control unit. The skin and connective tissues
overlying the anterior aspects of the left knee and the medial aspect
of the thigh were incised from the inguinal fossa to a point
immediately below the medial condyle of the tibia. The lower part of
the leg was attached to a platform for stability. The medial aspect of
the leg was exposed and an oil pool was created using the skin of the
hind-limb; this was ﬁlled with warmed (37  C) mineral oil (Sigma,
UK). The left saphenous nerve (contralateral to inﬂammation), which
innervates the hind-limb including the knee joint, was dissected free
from connective tissue at a point proximal to the knee joint and
sectioned to prevent recording afferent activity from more distal parts
of the rat hind-limb.
Extracellular recording
The saphenous nerve was placed on a dental mirror, teased and placed
onto bipolar platinum recording electrodes for differential recording of
multiunit neuronal activity. Teased ﬁlaments were derived from the
lateral aspect of the saphenous nerve, where knee joint afferents are
located within the medial articular nerve as it runs parallel to and then
joins the saphenous nerve. Identical recordings were also performed in
control rats that did not receive an injection of CFA. In these
preliminary experiments, neuronal activity was recorded for a 20-min
period following placement of the nerve onto the electrodes. Recorded
activity was ampliﬁed, ﬁltered and captured for off-line analysis by a
micro1401 (Cambridge Electronic Design, UK) and PC interface
(Viglen) using Spike 2 software (Cambridge Electronic Design).
Throughout, levels of activity were quantiﬁed as the frequency of
action potentials (1-s bins) over 5-min periods. In some experiments,
capsaicin (2%; n ¼ 6) or lignocaine (2%; n ¼ 6) was applied directly
onto the nerve at a site proximal to the recording site, and effects on
the frequency of the recorded activity were followed for between 20
and 25 min. In a separate set of experiments in CFA-injected rats
(n ¼ 12), following 1 h of baseline recordings of antidromic activity,
dipyrone (50–250 mg⁄kg in saline) was injected i.v. and effects on
neuronal activity were followed for 1 h per dose. The concentrations
of dipyrone were selected on the basis of past work, demonstrating the
inhibitory effect of dipyrone on spinal nociceptive transmission
(Neugebauer et al., 1994). As vehicle controls, identical experiments
were carried out except that dipyrone was replaced by four injections
of saline (100 lL, i.v.) and levels of activity were followed for 1 h per
administration of saline.
Plasma extravasation experiments
Rats that had received a knee joint injection of CFA (4 days
previously) were anaesthetized (pentobarbital 60 mg⁄kg, i.p.) and
the external jugular vein and trachea cannulated. Following a period of
time to allow for stabilization after the acute effects of surgery ( 30–
40 min), Evans blue dye (50 mg⁄kg, i.v.) was injected. Twenty
minutes after Evans blue administration rats were perfused transcar-
dially with saline. Both knee joints were rapidly dissected, cleaned of
skin and muscle, weighed and placed into formamide then onto a
roller for 24 h at room temperature. Levels of extracted Evans blue
dye were measured spectrophotomically (620 nm) and expressed as
lg⁄mL⁄g. The Evans blue technique is a well-established method and
has been routinely used to assess the effects of nociceptive afferent
stimulation on vascular function (Janig & Lisney, 1989; Bharali &
Lisney, 1992; Kolston & Lisney, 1993).
Statistical analysis
Data are expressed as mean and SEM. Statistical analysis was carried
out with nonparametric t-test (Mann–Whitney), paired t-test and
nonparametric one-way anova, where appropriate.
Results
Development of arthritis
All rats that received an intra-articular injection of CFA, 3–5 days
previously, developed a signiﬁcant unilateral and localized swelling of
the right knee joint (ipsilateral, 1.32 ± 0.03; contralateral,
0.91 ± 0.01 cm diameter; P < 0.0001, ipsilateral vs. contralateral,
paired t-test, n ¼ 32). In a separate behavioural study carried out using
rats of the same sex, age and weight as those used in the present study,
mean knee joint diameters (left and right) of control rats (n ¼ 6) were
0.91 ± 0.01 cm (P<0.001, Mann–Whitney). The ipsilateral knee
joint diameters of CFA rats used in the present neurophysiological
study were signiﬁcantly swollen compared to these control knee joint
diameters (P<0.0001, Mann–Whitney), whereas contralateral knee
joint diameters were identical.
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Fig. 1. Effect of CFA-induced knee joint inﬂammation on contralateral antidromic activity. (A and B) Plot of spontaneous antidromic action potentials (peak to
peak) recorded from the left saphenous nerve over a 5-min period from a typical experiment in (A) a CFA rat and (B) a control rat. (C) The mean frequency
of spontaneous antidromic APs recorded from the left saphenous nerve over a 20-min period was signiﬁcantly higher in rats that received an intra-articular injection
of CFA (250 lg ⁄ 100 lL; n ¼ 16) into the right knee joint than in control noninjected rats (n ¼ 5); **P<0.01 vs. controls. Lines represent median levels of
spontaneous activity.
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nociceptive thresholds had occurred, as all rats favoured the injected
hind-limb. We have previously noted that there is a signiﬁcant
decrease in the gait score and in the percentage of weight borne by the
injected limb in this model (Kelly & Donaldson, 2005), in agreement
with others’ observations (Wilson et al., 2006).
Recording of spontaneous antidromic activity in CFA rats
Three to ﬁve days following the induction of CFA-induced inﬂam-
mation of the right knee joint we were able to record both
mechanically evoked (data not shown) and spontaneous antidromic
neuronal activity from the left (contralateral) saphenous nerve (Fig. 1A
and C). The mechanically evoked activity was neither robust nor
reproducible and we therefore concentrated on the study of sponta-
neous neuronal activity. To determine whether this neuronal activity
was due to the presence of inﬂammation in the right knee-joint, we
carried out identical experiments in control noninjected rats (n ¼ 5).
Over the same time course of recording as in CFA rats (0–20 min),
control rats exhibited very low levels of antidromic activity (Fig. 1B
and C); when statistical comparisons were made between the two
groups the activity recorded contralateral to inﬂammation in CFA rats
was signiﬁcantly higher than that seen in untreated control rats
(P<0.01, Mann–Whitney; Fig. 1C). In one experiment, sectioning of
the saphenous nerve innervating the inﬂamed joint during recording,
thereby interrupting enhanced input from the site of inﬂammation, had
no effect on contralateral spontaneous activity (data not shown).
In our experiments the saphenous nerve was sectioned distally to
exclude the possibility that any recorded activity originated in the
periphery rather than being centrally generated. To conﬁrm that the
recorded activity was truly of central origin we applied the local
anaesthetic lignocaine (2%) directly onto the nerve proximal to the
recording site (between the spinal cord and the contralateral joint;
Fig. 2A). Lignocaine caused an almost complete abolition of the
recorded activity within seconds of application (Fig. 2A). Spontaneous
antidromic activity began to recover at  15–20 min and was complete
by 1 h (data not shown). As the saphenous nerve is known to contain
both sensory and sympathetic nerve ﬁbres in an approximate ratio of
4 : 1 (Baron et al., 1995), we sought to clarify whether the activity
observed was of sensory or sympathetic origin. We applied capsaicin
(2%), an agonist at the TRPV1 receptor known to block sensory
transmission, directly onto the nerve at a site proximal to the recording
site (n ¼ 6; Fig. 2B). Capsaicin was able to almost completely abolish
the recorded activity, which did not recover over the time-course
studied (Fig. 2B). In some experiments there was a small amount of
residual activity present following application of capsaicin.
Effects of systemic nonsteroidal anti-inﬂammatory drug
administration on spontaneous antidromic activity in CFA rats
In inﬂamed animals, in the absence of any drugs other than anaesthetic
and saline (i.v.), the frequency of contralateral spontaneous activity
increased over time (0–5 h; Fig. 3B). In order to investigate whether a
clinicallyrelevantpharmacologicalagentcouldmodulatetheincreasing
levels of spontaneous antidromic activity seen following CFA-induced
inﬂammation, we administered the paracetamol (acetaminophen)-
related centrally acting analgesic, dipyrone (50–250 mg⁄kg, i.v.), and
studied the effect on the frequency of spontaneous antidromic action
potentials. In most cases (5⁄7 experiments) dipyrone reduced the
frequency of spontaneous antidromic activity to levels approaching
or even below baseline levels of activity (Fig. 3A). Overall, the
administration of dipyrone reduced the activity in contralateral
sensory neurons, inhibiting the increase in activity over time that
was apparent in saline control experiments (Fig. 3B). There was a
signiﬁcant effect of dipyrone over time, as shown by a signiﬁcant
reduction in the area under the curve (AUC) in the presence of
dipyrone compared with saline control experiments (Fig. 3C;
P < 0.05, Mann–Whitney).
Plasma extravasation measurement in rat knee joints
When injected, intravascular Evans blue dye binds to plasma proteins
and acts as a marker for areas of extravasation. We used this method to
investigate whether there were differences in the level of plasma
extravasation between joints that were contralateral to inﬂammation
and showed no overt signs of inﬂammation, and those that were
contralateral to normal noninﬂamed control joints.
When comparing the plasma extravasation seen in ipsilateral joints
of CFA-inﬂamed rats and that seen in control noninﬂamed joints (right
and left control joints were pooled as there were no signiﬁcant
differences between them), the level of extravasation was signiﬁcantly
greater, as expected (P<0.001, Kruskal–Wallis). Importantly, the
level of Evans blue extravasation seen in joints contralateral to
inﬂammation was also signiﬁcantly greater than that seen in control
Fig. 2. Spontaneous antidromic action potentials originated centrally and
were transmitted by capsaicin-sensitive sensory neurons. (A) Lignocaine (2%)
and (B) capsaicin (2%) applied directly onto the nerve proximal to the
recording site in CFA rats (n ¼ 5 or 6) blocked the generation of spontaneous
antidromic APs. *P<0.05, **P<0.01.
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signiﬁcantly different from the values for the inﬂamed joints. The
median Evans blue extravasation in the contralateral joints was
intermediate to the control and ipsilateral inﬂamed joints (Fig. 4A).
The Evans blue assay is frequently misinterpreted as a measure of
vascular permeability (see Discussion) and might therefore be
assumed to correlate well with oedema. However, when joint swelling
(diameter) is compared to Evans blue extravasation, it is clear that
although joints contralateral to inﬂammation have high Evans blue
levels (Fig. 4B) they do not show any swelling. This indicates that
Evans blue extravasation can be increased under circumstances where
vascular permeability is not clearly altered. This implies that, in joints
contralateral to an overt inﬂammation, vascular function is altered but
vascular permeability (leading to oedema) probably is not.
Discussion
Animal models of RA demonstrate symmetry of joint involvement
(Donaldson et al., 1993), and provide an ideal opportunity for the
study of underlying mechanisms and development of potential
treatment strategies. In the past, use of these models, combined with
nerve lesion, has provided evidence that suggests that neurogenic
mechanisms are central to the development and maintenance of
contralateral effects (Levine et al., 1985b; Bileviciute et al., 1993;
Fig. 3. Effect of systemic dipyrone (50–250 mg ⁄ kg i.v.) on the frequency of spontaneous antidromic action potentials (APs). (A) An example of the time course
of the effect of systemic dipyrone on the frequency of spontaneous antidromic APs in a single experiment. (B) Mean data for the effect of systemic dipyrone (50–
250 mg ⁄ kg i.v.; n ¼ 7) and saline (4 · 100 lL i.v.; n ¼ 5) on the frequency of spontaneous antidromic APs in rats with CFA-induced inﬂammation of the right
knee joint (n ¼ 12). Dipyrone (50 mg ⁄ kg) or 100 lL saline administered at time 0; dotted lines represent the subsequent administration of dipyrone (100–
250 mg ⁄ kg i.v.) or three further saline administrations (100 lL i.v. each). (C) Area under the curve (AUC) analysis for the cumulative effect of systemic dipyrone
and saline on spontaneous antidromic APs; *P<0.05.
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et al., 1996; Decaris et al., 1999; Lombard et al., 1999; Lam et al.,
2004). However, few electrophysiological studies have been carried
out to directly investigate the functional plasticity that occurs in
contralateral sensory nerves following the induction of arthritis. Our
data describe for the ﬁrst time that a sensory nerve contralateral to
arthritis conducts spontaneous action potentials towards the periphery.
In addition, our data provide evidence that the function of the vascular
system is also altered in the contralateral knee joint. We report that
these changes occurred prior to overt signs of symmetrical inﬂamma-
tion and hypothesize that the reported plasticity has important
implications for the spread of inﬂammation in this model and may
mirror changes seen in man. Importantly, we were able to demonstrate
that intervention with a centrally acting analgesic was able to modulate
contralateral neuronal activity.
In the present study, contralateral spontaneous antidromic nerve
activity was dependent on the presence of inﬂammation and could be
abolished with lignocaine and capsaicin applied directly to the nerve
trunk. Thus, we have conﬁrmed that this activity was neural,
originated centrally and occurred in TRPV1-expressing sensory ﬁbres
(Pini & Lynn, 1991). In some CFA animals we observed that a small
amount of residual neuronal activity was present following capsaicin
application, implying that there may be altered activity in contralateral
sympathetic efferents (Helliwell et al., 1998; Tominaga et al., 1998;
Smith et al., 2004; Moalem et al., 2005). However, perineural
capsaicin prevents the symmetrical spread of arthritis in this model
(Donaldson et al., 1995), implying that it is capsaicin-sensitive
sensory neurons that are pivotal to the symmetrical progression of
arthritis.
Antidromic activity in sensory nerves (dorsal root reﬂexes; DRRs)
is a form of primary afferent depolarization (PAD) generated by the
action of GABA at GABAA receptors on the central terminals of
primary afferents (Willis, 1999). Under physiological conditions PAD
acts to reduce the amount of neurotransmitter released centrally
leading to presynaptic inhibition (Willis, 1999). However, under
pathological conditions DRRs may be generated and transmitted
towards the periphery where they contribute to the development of
inﬂammation (Rees et al., 1994; Lin et al., 1999). It is likely that the
spontaneous antidromic neural activity we report represents sponta-
neous DRRs that could be an important contributor to the development
of contralateral inﬂammation. Indeed, antidromic stimulation of
sensory nerves leads to the release of the pro-inﬂammatory neuro-
peptides SP and CGRP (White & Helme, 1985). We have demon-
strated that inﬂamed animals have greatly enhanced levels of
spontaneous antidromic activity compared to noninﬂamed control
animals, possibly due to the central sensitization of primary afferents.
The increasing spontaneous activity we see over time in inﬂamed
animals is probably a consequence of the interaction of the barbiturate
anaesthetic pentobarbital with GABAA receptors, further enhancing
this already sensitized system (Nicoll & Wojtowicz, 1980; Feng et al.,
2004). Mechanically evoked contralateral DRRs have previously been
reported in this model, but are less robust and more inconsistent (Rees
et al., 1996, and present study). Arthritic joints tend to be guarded and
little weight is borne on them (Kelly & Donaldson, 2005; Wilson
et al., 2006). As a consequence of this altered behaviour, mechanically
evoked antidromic activity may contribute less to the neurogenic
component involved in the development of contralateral inﬂammation
than activity occurring spontaneously.
Here, we provide the ﬁrst report of modulatory effects of a centrally
acting analgesic on contralateral proinﬂammatory nerve activity.
Systemic dipyrone, at concentrations that have inhibitory effects on
spinal nociceptive transmission (Neugebauer et al., 1994), was able to
inhibit spontaneous antidromic nerve activity. Inhibition was not,
however, complete, suggesting that spontaneous contralateral DRRs
may be well established only 3 days after the onset of unilateral
inﬂammation. Although dipyrone inhibits activity in primary afferents
innervating an arthritic joint (Neugebauer et al., 1994; Ferreira, 2002;
Kelly & Donaldson, 2005), in a single experiment in which ipsilateral
afferent input was interrupted there was no effect on spontaneous
contralateral output, suggesting that a peripheral action of dipyrone
may not be key in the effects we observe. Evidence suggests that both
spinal and supraspinal pathways may be involved in the generation of
contralateral responses (Thompson & Bywaters, 1962; Levine et al.,
1985a; Bileviciute et al., 1998; Eide et al., 1999; Peng et al., 2001).
Hence, it is likely that dipyrone acts at central sites to modulate
contralateral responses (Beirith et al., 1998; Mazario & Herrero, 1999;
Ferreira, 2002). Dipyrone has an inhibitory action on cyclooxygenase
(COX) enzymes (Abbate et al., 1989; Abbate et al., 1990) and, in the
periphery, stimulates the NO–cGMP pathway (Sachs et al., 2004);
both of these proposed mechanisms may contribute to its reported
analgesic action. COX2 mRNA and NO synthase are up-regulated
bilaterally at the spinal cord level during peripheral inﬂammation
(Beiche et al., 1996; Ichitani et al., 1997; Dolan et al., 2000).
Importantly, prostaglandins (products of COX enzymes) and NO are
involved in spinal nociceptive processing (Dirig et al., 1997; Tegeder
et al., 2001; Vanegas & Schaible, 2001; Nakayama et al., 2004) and
the regulation of the excitability of the central terminals of primary
afferents (Beirith et al., 1998). It is likely, therefore, that the
mechanism by which dipyrone modulated contralateral antidromic
Fig. 4. Effect of CFA-induced inﬂammation of the knee joint on ipsilateral
and contralateral Evans blue dye extravasation (lg ⁄ mL ⁄ g tissue). (A) Amoun-
t of Evans blue extracted from the ipsilateral and contralateral knee joints of
CFA rats (n ¼ 11) was signiﬁcantly greater than that extracted from knee joints
(left and right) of control rats (n ¼ 4), ***P<0.001, *P<0.05 vs. control.
Lines represent medians. (B) Evans blue extravasation vs. ipsilateral (Ipsi),
contralateral (Contra) and control (left and right) knee joint diameter.
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and⁄or the stimulation of NO–cGMP activity.
Importantly, the spontaneous activity we report is of a frequency
known to result in neurogenic inﬂammation following electrical
stimulation of peripheral nerves, through release of SP and CGRP
(White & Helme, 1985). SP and CGRP increase vascular permeability,
perfusion (through vasodilatory effects) and plasma protein leakage
from cutaneous vessels (Holzer, 1998), and are thought to play an
important role in the contralateral spread of arthritis (Bileviciute et al.,
1998; Decaris et al., 1999; Lam et al., 2004). In contralateral joints,
there was an increase in plasma extravasation that was associated with
the reported spontaneous antidromic sensory nerve activity but was
not associated with overt swelling. The degree of Evans blue
extravasation into tissue is a measure of combined effects on blood
ﬂow, capillary pressure, capillary permeability and many other factors
(Bates et al., 1999). Many or all of these factors may be altered in
early inﬂammation. Our ﬁndings indicate a change in one or several of
these parameters in contralateral joints, but probably exclude a
permeability change. Increased perfusion and vasodilation in the
contralateral joints could be indicative of a ‘preinﬂammatory’state that
these data suggest occurs only 4 days after the onset of monoarthritis.
These vascular changes are slightly smaller than those ipsilateral to the
inﬂammation, a ﬁnding common to many studies (for reviews see
Donaldson, 1999; Shenker et al., 2003).
Our ﬁndings indicate that central changes contributing to the
generation of antidromic activity and the subsequent alterations in
vascular function are already established by 3–5 days after CFA
injection. The relatively short time frame of the reported changes is in
agreement with previous reports of bilateral effects (Kidd et al., 1995;
Rees et al., 1996). Interestingly, antidromic stimulation of nerves at
C-ﬁbre intensity evokes both unilateral (Janig & Lisney, 1989) and
bilateral plasma extravasation (Ferrell & Russell, 1986), which
suggests that altered sensory input to the spinal cord can induce very
rapid changes in contralateral output. Knee joint plasma extravasation
resulting from peripheral nerve stimulation is sensory afferent-
dependent with no contribution from sympathetic efferents, which
are, in fact, responsible for a diminution in plasma extravastion (Ferrell
& Russell, 1986). Although sympathetic efferents have been impli-
cated in the development of arthritis (Aloe et al., 1992; Bileviciute
et al., 1995; Lubahn et al., 2004) and in the spread of inﬂammation
(Levine et al., 1986) their possible contribution is still not clear.
To summarize, our data show that there is a neuronal correlate
underlying contralateral inﬂammatory changes, manifested as ongoing
antidromic activity in sensory neurons that is capable of altering
contralateral articular perfusion very early in the disease. The early
onset of contralateral changes will pose a challenge for the treatment
of RA, but our ﬁnding that the centrally acting analgesic dipyrone can
reduce the contralateral antidromic activity indicates that early
intervention with this class of drugs may be useful in preventing the
spread of arthritis. Understanding the neuronal mechanisms that
underlie the spread of arthritis is of clear clinical relevance so that we
may slow the progression of this destructive and debilitating disease.
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